Close
Digital Health & Ai Innovation summit 2026
Medica Compamed 2026

AI Detection Programs Combat Drug Diversion In Hospitals

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Norton Healthcare Launches $30 Million High-Tech...

Norton Healthcare has officially opened a new $30 million...

OSF HealthCare Expands RapidAI Platform Across...

OSF HealthCare is expanding its deployment of advanced stroke...

Innovaccer and Mastek Form Strategic Healthcare...

Innovaccer and Mastek have announced a strategic healthcare AI...

Research conducted by Wolters Kluwer, an information and software company, suggests that artificial intelligence (AI) can potentially reduce drug diversion in hospitals. The study revealed that over half of managers who implemented AI-based diversion detection programs reported increased confidence in their effectiveness.

Drug diversion involves the illegal redirection of prescription medications from their intended clinical use, often involving medical staff either using these drugs for themselves or selling them for personal gain. The International Health Facility Diversion Association estimates that at least 37,000 diversion incidents occur annually in U.S. healthcare facilities.

Karen Kobelski, Vice President and General Manager of Clinical Surveillance Compliance & Data Solutions at Wolters Kluwer Health, highlighted that the issue has been exacerbated by the use of temporary and contract staff during the COVID-19 pandemic. She emphasized the importance of advanced technology in maintaining effective diversion detection programs, considering the risks to patient safety, clinical teams, and the hospital’s reputation and finances.

The survey, titled “The State of Drug Diversion 2023 Report,” revealed that 71 percent of respondents stated their drug diversion teams spend approximately eight hours on each investigation, impacting their ability to address the problem efficiently. The survey, conducted in the U.S. and produced by Eliciting Insights, involved 100 healthcare professionals. Its aim was to assess the confidence of healthcare facilities in their anti-drug diversion systems, both with and without the use of AI tools.

In 2019, only 29 percent of respondents used AI tracking to identify potential drug diversion cases. However, the 2023 results indicate a significant increase, with 56 percent of respondents now utilizing AI tools. Among those employing AI, more than half expressed confidence in the effectiveness of these tools in preventing the loss of prescription drugs.

Kobelski emphasized the value of AI-based diversion detection programs, as they can efficiently analyze large volumes of data to identify suspicious cases. This is especially beneficial for resource-strapped hospitals that may not have dedicated staff for continuous diversion detection programs, allowing them to effectively detect and address diversion incidents.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Norton Healthcare Launches $30 Million High-Tech Automated Pharmacy Hub

Norton Healthcare has officially opened a new $30 million...

OSF HealthCare Expands RapidAI Platform Across 18 Hospitals to Speed Stroke Care

OSF HealthCare is expanding its deployment of advanced stroke...

Innovaccer and Mastek Form Strategic Healthcare AI Partnership

Innovaccer and Mastek have announced a strategic healthcare AI...

Chinese Researchers Develop OneGenome Genomic AI System for Rare Disease Diagnosis

Chinese researchers have introduced an open-source genomic AI system...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป